{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:13:17Z","timestamp":1787314397800,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T00:00:00Z","timestamp":1384819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s13277-013-1374-y","type":"journal-article","created":{"date-parts":[[2013,11,18]],"date-time":"2013-11-18T02:41:44Z","timestamp":1384742504000},"page":"2817-2824","source":"Crossref","is-referenced-by-count":28,"title":["High fibroblast growth factor 19 (FGF19) expression predicts worse prognosis in invasive ductal carcinoma of breast"],"prefix":"10.1007","volume":"35","author":[{"given":"Abdelbaset","family":"Buhmeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Dallol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Merdad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaudah","family":"Al-Maghrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamdooh A.","family":"Gari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad M.","family":"Abu-Elmagd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel G.","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel M.","family":"Abuzenadah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taoufik","family":"Nedjadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eramah","family":"Ermiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Al-Thubaity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed H.","family":"Al-Qahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,19]]},"reference":[{"key":"1374_CR1","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(11)61351-2","volume":"378","author":"MH Forouzanfar","year":"2011","unstructured":"Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378:1461\u201384.","journal-title":"Lancet"},{"key":"1374_CR2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/1756-0500-5-452","volume":"5","author":"E Ermiah","year":"2012","unstructured":"Ermiah E, Abdalla F, Buhmeida A, Larbesh E, Pyrhonen S, Collan Y. Diagnosis delay in Libyan female breast cancer. BMC Research Notes. 2012;5:452.","journal-title":"BMC Research Notes"},{"key":"1374_CR3","unstructured":"Ikpatt F. Nigerian breast cancer: prognostic value of histomorphometry. Turku: Annales Universitatis Turkuensis 2002; 487, 128 pages"},{"key":"1374_CR4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1524-4741.2012.01242.x","volume":"18","author":"N Missaoui","year":"2012","unstructured":"Missaoui N, Landolsi H, Jaidaine L, Ben Abdelkader A, Yaacoubi MT, Hmissa S. Breast cancer in central Tunisia: an earlier age at diagnosis and incidence increase over a 15-year period. Breast J. 2012;18:289\u201391.","journal-title":"Breast J"},{"key":"1374_CR5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ijsu.2010.05.012","volume":"8","author":"H Najjar","year":"2010","unstructured":"Najjar H, Easson A. Age at diagnosis of breast cancer in Arab nations. Int J Surg (London, England). 2010;8:448\u201352.","journal-title":"Int J Surg (London, England)"},{"key":"1374_CR6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1471-2407-12-299","volume":"12","author":"S Taghipour","year":"2012","unstructured":"Taghipour S, Banjevic D, Fernandes J, et al. Predictors of competing mortality to invasive breast cancer incidence in the Canadian National Breast Screening study. BMC Cancer. 2012;12:299.","journal-title":"BMC Cancer"},{"key":"1374_CR7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4048\/jbc.2013.16.1.16","volume":"16","author":"SP Jung","year":"2013","unstructured":"Jung SP, Kim S, Nam SJ, Kim I, Bae JW. The role of the CDH1 promoter hypermethylation in the axillary lymph node metastasis and prognosis. J Breast Cancer. 2013;16:16\u201322.","journal-title":"J Breast Cancer"},{"key":"1374_CR8","doi-asserted-by":"crossref","first-page":"e55901","DOI":"10.1371\/journal.pone.0055901","volume":"8","author":"F Reyal","year":"2013","unstructured":"Reyal F, Hajage D, Savignoni A, et al. Long-term prognostic performance of ki67 rate in early stage, p T1\u2013pT2, pN0, invasive breast carcinoma. PLoS One. 2013;8:e55901.","journal-title":"PLoS One"},{"key":"1374_CR9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2045-3701-3-16","volume":"3","author":"Y Huang","year":"2013","unstructured":"Huang Y, Zhang H, Cai J, et al. Overexpression of MACC1 and its significance in human breast cancer progression. Cell Biosci. 2013;3:16.","journal-title":"Cell Biosci"},{"key":"1374_CR10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01840834","volume":"22","author":"MH Galea","year":"1992","unstructured":"Galea MH, Blamey RW, Elston CE, Ellis IO. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat. 1992;22:207\u201319.","journal-title":"Breast Cancer Res Treat"},{"key":"1374_CR11","doi-asserted-by":"crossref","unstructured":"Jiang L, Zhou Y, Wang Z, Lu X, Chen M, Zhou C. Is there different correlation with prognostic factors between \u201cnon-mass\" and \u201cmass\u201d type invasive ductal breast cancers? Eur J Radiol. 2013;82(9):1404\u20139","DOI":"10.1016\/j.ejrad.2013.03.006"},{"key":"1374_CR12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0167-8140(88)90222-8","volume":"13","author":"F Thomas","year":"1988","unstructured":"Thomas F, Arriagada R, Mouriesse H, et al. Radical radiotherapy alone in non-operable breast cancer: the major impact of tumor size and histological grade on prognosis. Radiother Oncol: J Eur Soc Ther Radiol Oncol. 1988;13:267\u201376.","journal-title":"Radiother Oncol: J Eur Soc Ther Radiol Oncol"},{"key":"1374_CR13","unstructured":"Visscher DW, Zarbo RJ, Greenawald KA, Crissman JD. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast. Pathology Annual. 1990; 25 Pt 1: 171\u2013210."},{"key":"1374_CR14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.critrevonc.2010.01.011","volume":"77","author":"O Metzger Filho","year":"2011","unstructured":"Metzger Filho O, Ignatiadis M, Sotiriou C. Genomic Grade Index: an important tool for assessing breast cancer tumor grade and prognosis. Crit Rev Oncol Hematol. 2011;77:20\u20139.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1374_CR15","doi-asserted-by":"crossref","first-page":"e60576","DOI":"10.1371\/journal.pone.0060576","volume":"8","author":"CB Pereira","year":"2013","unstructured":"Pereira CB, Leal MF, de Souza CR, et al. Prognostic and predictive significance of MYC and KRAS alterations in breast cancer from women treated with neoadjuvant chemotherapy. PLoS One. 2013;8:e60576.","journal-title":"PLoS One"},{"key":"1374_CR16","doi-asserted-by":"crossref","unstructured":"Zhou L, Luo Y, Li K, et al. Molecular markers of therapeutic resistance in breast cancer. Hum Pathol. 2013;44(7):1421\u20138.","DOI":"10.1016\/j.humpath.2012.10.027"},{"key":"1374_CR17","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/hep.25929","volume":"56","author":"C Cicione","year":"2012","unstructured":"Cicione C, Degirolamo C, Moschetta A. Emerging role of fibroblast growth factors 15\/19 and 21 as metabolic integrators in the liver. Hepatology (Baltimore, Md). 2012;56:2404\u201311.","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"1374_CR18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-4614-0887-1_12","volume":"728","author":"BC Lin","year":"2012","unstructured":"Lin BC, Desnoyers LR. FGF19 and cancer. Adv Exp Med Biol. 2012;728:183\u201394.","journal-title":"Adv Exp Med Biol"},{"key":"1374_CR19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1582-4934.2008.00506.x","volume":"14","author":"X Wu","year":"2010","unstructured":"Wu X, Yan Q, Huang Y, et al. Isolation of a novel basic FGF-binding peptide with potent antiangiogenetic activity. J Cell Mol Med. 2010;14:351\u20136.","journal-title":"J Cell Mol Med"},{"key":"1374_CR20","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ydbio.2007.11.013","volume":"313","author":"Y Nakayama","year":"2008","unstructured":"Nakayama Y, Miyake A, Nakagawa Y, et al. Fgf19 is required for zebrafish lens and retina development. Dev Biol. 2008;313:752\u201366.","journal-title":"Dev Biol"},{"key":"1374_CR21","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1158\/0008-5472.CAN-12-4108","volume":"73","author":"S Feng","year":"2013","unstructured":"Feng S, Dakhova O, Creighton CJ, Ittmann M. Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression. Cancer Res. 2013;73:2551\u201362.","journal-title":"Cancer Res"},{"key":"1374_CR22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccr.2011.01.040","volume":"19","author":"ET Sawey","year":"2011","unstructured":"Sawey ET, Chanrion M, Cai C, et al. Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by oncogenomic screening. Cancer Cell. 2011;19:347\u201358.","journal-title":"Cancer Cell"},{"key":"1374_CR23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2407-12-56","volume":"12","author":"S Miura","year":"2012","unstructured":"Miura S, Mitsuhashi N, Shimizu H, et al. Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma. BMC Cancer. 2012;12:56.","journal-title":"BMC Cancer"},{"key":"1374_CR24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.breast.2012.07.010","volume":"22","author":"M Ly","year":"2013","unstructured":"Ly M, Valent A, Diallo G, et al. Gene copy number variations in breast cancer of Sub-Saharan African women. Breast (Edinburgh, Scotland). 2013;22:295\u2013300.","journal-title":"Breast (Edinburgh, Scotland)"},{"key":"1374_CR25","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0002-9440(10)61177-7","volume":"160","author":"K Nicholes","year":"2002","unstructured":"Nicholes K, Guillet S, Tomlinson E, et al. A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. Am J Pathol. 2002;160:2295\u2013307.","journal-title":"Am J Pathol"},{"key":"1374_CR26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.onc.1210623","volume":"27","author":"LR Desnoyers","year":"2008","unstructured":"Desnoyers LR, Pai R, Ferrando RE, et al. Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. Oncogene. 2008;27:85\u201397.","journal-title":"Oncogene"},{"key":"1374_CR27","doi-asserted-by":"crossref","first-page":"29069","DOI":"10.1074\/jbc.C700130200","volume":"282","author":"X Wu","year":"2007","unstructured":"Wu X, Ge H, Gupte J, et al. Co-receptor requirements for fibroblast growth factor-19 signaling. J Biol Chem. 2007;282:29069\u201372.","journal-title":"J Biol Chem"},{"key":"1374_CR28","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1158\/0008-5472.CAN-07-2325","volume":"68","author":"R Pai","year":"2008","unstructured":"Pai R, Dunlap D, Qing J, Mohtashemi I, Hotzel K, French DM. Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating beta-catenin signaling. Cancer Res. 2008;68:5086\u201395.","journal-title":"Cancer Res"},{"key":"1374_CR29","doi-asserted-by":"crossref","first-page":"27277","DOI":"10.1074\/jbc.M704244200","volume":"282","author":"BC Lin","year":"2007","unstructured":"Lin BC, Wang M, Blackmore C, Desnoyers LR. Liver-specific activities of FGF19 require Klotho beta. J Biol Chem. 2007;282:27277\u201384.","journal-title":"J Biol Chem"},{"key":"1374_CR30","doi-asserted-by":"crossref","first-page":"43294","DOI":"10.1074\/jbc.M111.267641","volume":"286","author":"J Kim","year":"2011","unstructured":"Kim J, Eskiocak U, Stadler G, et al. Short hairpin RNA screen indicates that Klotho beta\/FGF19 protein overcomes stasis in human colonic epithelial cells. J Biol Chem. 2011;286:43294\u2013300.","journal-title":"J Biol Chem"},{"key":"1374_CR31","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10549-011-1824-4","volume":"133","author":"T Rubinek","year":"2012","unstructured":"Rubinek T, Shulman M, Israeli S, et al. Epigenetic silencing of the tumor suppressor klotho in human breast cancer. Breast Cancer Res Treat. 2012;133:649\u201357.","journal-title":"Breast Cancer Res Treat"},{"key":"1374_CR32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00002.2011","volume":"92","author":"A Martin","year":"2012","unstructured":"Martin A, David V, Quarles LD. Regulation and function of the FGF23\/klotho endocrine pathways. Physiol Rev. 2012;92:131\u201355.","journal-title":"Physiol Rev"},{"key":"1374_CR33","doi-asserted-by":"crossref","first-page":"33304","DOI":"10.1074\/jbc.M803319200","volume":"283","author":"X Wu","year":"2008","unstructured":"Wu X, Lemon B, Li X, et al. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors. J Biol Chem. 2008;283:33304\u20139.","journal-title":"J Biol Chem"},{"key":"1374_CR34","first-page":"125","volume":"11","author":"P Lipponen","year":"1992","unstructured":"Lipponen P, Collan Y. Simple quantitation of immuno-histochemical staining positivity in microscopy. Acta Stereol. 1992;11:125\u201332.","journal-title":"Acta Stereol"},{"key":"1374_CR35","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.3748\/wjg.14.4903","volume":"14","author":"A Elzagheid","year":"2008","unstructured":"Elzagheid A, Buhmeida A, Korkeila E, Collan Y, Syrjanen K, Pyrhonen S. Up-regulation of alpha-catenin is associated with increased lymph node involvement in colorectal cancer. World J Gastroenterol. 2008;14:4903\u20138.","journal-title":"World J Gastroenterol"},{"key":"1374_CR36","first-page":"1771","volume":"29","author":"F Abdalla","year":"2009","unstructured":"Abdalla F, Boder J, Markus R, Hashmi H, Buhmeida A, Collan Y. Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis. Anticancer Res. 2009;29:1771\u20136.","journal-title":"Anticancer Res"},{"key":"1374_CR37","first-page":"2975","volume":"31","author":"A Buhmeida","year":"2011","unstructured":"Buhmeida A, Merdad A, Al-Maghrabi J, et al. RASSF1A methylation is predictive of poor prognosis in female breast cancer in a background of overall low methylation frequency. Anticancer Res. 2011;31:2975\u201381.","journal-title":"Anticancer Res"},{"key":"1374_CR38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000339788","volume":"83","author":"E Ermiah","year":"2012","unstructured":"Ermiah E, Abdalla F, Buhmeida A, et al. Prognostic significance of DNA image cytometry in Libyan breast cancer. Oncology. 2012;83:165\u201376.","journal-title":"Oncology"},{"key":"1374_CR39","doi-asserted-by":"crossref","unstructured":"Ermiah E, Buhmeida A, Khaled BR, et al. Prognostic value of bcl-2 expression among women with breast cancer in Libya. Tumour biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 2013.","DOI":"10.1007\/s13277-013-0687-1"},{"key":"1374_CR40","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2337\/db10-0004","volume":"59","author":"C Pfannenberg","year":"2010","unstructured":"Pfannenberg C, Werner MK, Ripkens S, et al. Impact of age on the relationships of brown adipose tissue with sex and adiposity in humans. Diabetes. 2010;59:1789\u201393.","journal-title":"Diabetes"},{"key":"1374_CR41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/nyas.12009","volume":"1281","author":"B Feng","year":"2013","unstructured":"Feng B, Zhang T, Xu H. Human adipose dynamics and metabolic health. Ann N Y Acad Sci. 2013;1281:160\u201377.","journal-title":"Ann N Y Acad Sci"},{"key":"1374_CR42","doi-asserted-by":"crossref","first-page":"e36713","DOI":"10.1371\/journal.pone.0036713","volume":"7","author":"DM French","year":"2012","unstructured":"French DM, Lin BC, Wang M, et al. Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models. PLoS One. 2012;7:e36713.","journal-title":"PLoS One"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-013-1374-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-013-1374-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-013-1374-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T01:53:15Z","timestamp":1564710795000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-013-1374-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,19]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["1374"],"URL":"https:\/\/doi.org\/10.1007\/s13277-013-1374-y","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,19]]}}}